Revelation Biosciences, Inc. REVB Stock
Revelation Biosciences, Inc. Price Chart
Revelation Biosciences, Inc. REVB Financial and Trading Overview
Revelation Biosciences, Inc. stock price | 2.68 USD |
Previous Close | 1.13 USD |
Open | 1.14 USD |
Bid | 0 USD x 1000 |
Ask | 0 USD x 1300 |
Day's Range | 1.09 - 1.18 USD |
52 Week Range | 0.95 - 67.9 USD |
Volume | 279.58K USD |
Avg. Volume | 682.81K USD |
Market Cap | 6.71M USD |
Beta (5Y Monthly) | 0.324126 |
PE Ratio (TTM) | 0.01677244 |
EPS (TTM) | -87.68 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15 USD |
REVB Valuation Measures
Enterprise Value | -10988580 USD |
Trailing P/E | 0.01677244 |
Forward P/E | -0.5311005 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.5240793 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | 1.871 |
Trading Information
Revelation Biosciences, Inc. Stock Price History
Beta (5Y Monthly) | 0.324126 |
52-Week Change | -92.95% |
S&P500 52-Week Change | 20.43% |
52 Week High | 67.9 USD |
52 Week Low | 0.95 USD |
50-Day Moving Average | 1.1 USD |
200-Day Moving Average | 5.71 USD |
REVB Share Statistics
Avg. Volume (3 month) | 682.81K USD |
Avg. Daily Volume (10-Days) | 221.54K USD |
Shares Outstanding | 6.05M |
Float | 5.75M |
Short Ratio | 0.24 |
% Held by Insiders | 10.42% |
% Held by Institutions | 1.85% |
Shares Short | 94.74K |
Short % of Float | 1.60% |
Short % of Shares Outstanding | 1.57% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:35 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -28.24% |
Return on Equity (ttm) | 39.24% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -5873009 USD |
Net Income Avi to Common (ttm) | 1.95M USD |
Diluted EPS (ttm) | 66.18 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 17.7M USD |
Total Cash Per Share (mrq) | 2.93 USD |
Total Debt (mrq) | 0 USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 2.226 |
Book Value Per Share (mrq) | 2.118 |
Cash Flow Statement
Operating Cash Flow (ttm) | -7964484 USD |
Levered Free Cash Flow (ttm) | -3090567 USD |
Profile of Revelation Biosciences, Inc.
Country | United States |
State | CA |
City | San Diego |
Address | 4660 La Jolla Village Drive |
ZIP | 92122 |
Phone | 650 800 3717 |
Website | https://www.revbiosciences.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 6 |
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-100, a potential therapy for the prevention and treatment of healthcare-associated bacterial infection resulting from surgery, severe burns, urinary tract infection, sepsis, and antibiotic resistance; REVTx-200, a potential intranasal therapy; and REVTx-300, a potential therapy for the treatment of chronic organ disease, including chronic kidney disease. It is also developing REVTx-99b, a treatment for food allergies; REVTx-99a, an anti-viral nasal drop solution for the potential prevention or treatment of respiratory viral infection; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, influenza A, influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.
Q&A For Revelation Biosciences, Inc. Stock
What is a current REVB stock price?
Revelation Biosciences, Inc. REVB stock price today per share is 2.68 USD.
How to purchase Revelation Biosciences, Inc. stock?
You can buy REVB shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Revelation Biosciences, Inc.?
The stock symbol or ticker of Revelation Biosciences, Inc. is REVB.
Which industry does the Revelation Biosciences, Inc. company belong to?
The Revelation Biosciences, Inc. industry is Biotechnology.
How many shares does Revelation Biosciences, Inc. have in circulation?
The max supply of Revelation Biosciences, Inc. shares is 905.23K.
What is Revelation Biosciences, Inc. Price to Earnings Ratio (PE Ratio)?
Revelation Biosciences, Inc. PE Ratio is now.
What was Revelation Biosciences, Inc. earnings per share over the trailing 12 months (TTM)?
Revelation Biosciences, Inc. EPS is -87.68 USD over the trailing 12 months.
Which sector does the Revelation Biosciences, Inc. company belong to?
The Revelation Biosciences, Inc. sector is Healthcare.
Revelation Biosciences, Inc. REVB included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}